Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Holding GLPG?
Track your performance easily
GLPG Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.16 - $42.46
Previous Close$27.13
Volume277.22K
Average Volume (3M)220.80K
Market Cap
$1.74B
Enterprise Value-$2.12B
Total Cash (Recent Filing)€3.68B
Total Debt (Recent Filing)€41.64M
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Feb 12, 2025EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding65,897,071
10 Day Avg. Volume405,004
30 Day Avg. Volume220,796
Standard Deviation0.09
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)0.60
Price to Sales (P/S)6.58
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$28.60Price Target Upside5.42% Upside
Rating ConsensusHold
Number of Analyst Covering6
Galapagos News
PremiumCompany Announcements
Galapagos NV Sees Pipeline Growth Amid Financial Challenges
Bulls Say, Bears Say
Bulls Say
Clinical AdvancementsGalapagos continues to advance 3 clinical-stage CAR T programs in oncology with promising early efficacy and clean safety data, providing validation for its 7 day vein-to-vein POC CAR T platform.
Strategic CollaborationsThe FDA has cleared the IND to expand the ATALANTA trial to the U.S., and Galapagos has entered into a strategic collaboration to further expand its CAR-T production system.
Strategic LeadershipThe appointment of an activist investor to the board is seen as a potential catalyst for movement, as it was considered the right time to bring in an individual with strong connections in the biotech ecosystem.
Bears Say
Business DevelopmentThere were no notable updates on business development efforts, which are crucial to win back investor confidence.
Investor SentimentInvestor perception is that the company’s current pipeline activities are likely value-destructive, as reflected by trading at ~50% of its cash on hand.
Pipeline RiskThe company's pipeline efforts are seen as inordinately risky, and BD is considered the best way to improve R&D outlook and rehabilitate investor sentiment.
---
Ownership Overview
―
Insiders
4.56% Mutual Funds
15.80% Other Institutional Investors
78.82% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GLPG FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest stock price was $24.16 and its highest was $42.45 in the past 12 months.
What is Galapagos’s market cap?
Currently, no data Available
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Feb 12, 2025 which is in 80 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on Oct 30, 2024. The company reported -$0.814 earnings per share for the quarter, missing the consensus estimate of -$0.169 by -$0.645.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Undervalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate is -$0.5.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of -$0.814 in its last earnings report, missing expectations of -$0.169. Following the earnings report the stock price went down -7.52%.
Which hedge fund is a major shareholder of Galapagos?
Among the largest hedge funds holding Galapagos’s share is Deerfield Management Company, LP. It holds Galapagos’s shares valued at 41M.
---
Galapagos Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$28.60 (5.42% Upside)
$28.60 (5.42% Upside)
Blogger Sentiment
Bullish
GLPG Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.69%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-1.20%
Trailing 12-Months
Company Description
Galapagos
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
---
GLPG Company Deck
---
GLPG Earnings Call
Q3 2024
0:00 / 0:00
---
GLPG Stock 12 Month Forecast
Average Price Target
$28.60
▲(5.42% Upside)
Technical Analysis
Best Analysts Covering GLPG
1 Year
1 Year Success Rate
7/14 ratings generated profit
1 Year Average Return
+15.56%
reiterated a buy rating 24 days ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +15.56% per trade.
---